Kandu Health and Neurolutions Announce Merger to Form Kandu, Inc., a New Leader in Stroke Recovery
Clinical Outcomes with IpsiHand
About 70%
of clinical trial participants improved arm and hand movement.
+8.1 Fugl-Meyer
In a recent study, eligible patients improved by an average of 8.1 points on the Fugl-Meyer Assessment, the leading test for arm function after stroke.
12 Weeks
Participants saw real improvement after just three months of using IpsiHand.
Reimagine stroke treatment with this brain-activated home therapy. IpsiHand is a brain-computer interface technology that is FDA-cleared to accelerate motor recovery after a stroke.